ArticleAmerican journal of cancer research2018

Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer.

Meiying Ji et al.PubMed ↗Full text ↗

No numbers read from the abstract.